Suppr超能文献

双重疫情期间的糖尿病管理

Management of Diabetes During a Dual Pandemic.

作者信息

Appel Susan J, Wadas Theresa M, Andrabi Mudasir S

出版信息

J Nurse Pract. 2021 Jun;17(6):680-686. doi: 10.1016/j.nurpra.2020.12.021. Epub 2021 Feb 15.

Abstract

The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2- to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19-positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted.

摘要

2019冠状病毒病(COVID-19)与患者糖尿病这两种大流行病与重症监护病房收治率高出2至3倍以及更高的死亡率相关。无论是居家隔离、新冠病毒检测呈阳性后被隔离,还是住院治疗,糖尿病患者在成功管理方面都需要特殊考虑。患有糖尿病且新冠病毒检测呈阳性会增加不良后果和死亡风险。在COVID-19封锁期间,医疗服务提供者需要为糖尿病患者提供预期的药物治疗指导。糖尿病患者需要比其他人更加注意,并采取自我保护措施。本综述(1)讨论了COVID-19、糖尿病的临床观察结果及潜在机制,(2)描述了在COVID-19环境中护理糖尿病患者的特殊考虑因素,(3)综述了对医疗服务提供者的临床意义。本综述突出了当前基于证据的知识。关于临床管理的更多研究是必要的。

相似文献

1
Management of Diabetes During a Dual Pandemic.
J Nurse Pract. 2021 Jun;17(6):680-686. doi: 10.1016/j.nurpra.2020.12.021. Epub 2021 Feb 15.
3
Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review.
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1109-1120. doi: 10.1016/j.dsx.2020.06.070. Epub 2020 Jul 4.
7
The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth.
Diabetes Technol Ther. 2020 Jun;22(6):449-453. doi: 10.1089/dia.2020.0187. Epub 2020 May 5.
8
9
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa342.

本文引用的文献

1
Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19.
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e377-e381. doi: 10.1210/clinem/dgaa704.
2
Diabetes and COVID-19: A systematic review on the current evidences.
Diabetes Res Clin Pract. 2020 Aug;166:108347. doi: 10.1016/j.diabres.2020.108347. Epub 2020 Jul 22.
3
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792. doi: 10.1016/S2213-8587(20)30238-2. Epub 2020 Jul 17.
4
Musculoskeletal Consequences of COVID-19.
J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847.
6
The impact of physical activity on psychological health during Covid-19 pandemic in Italy.
Heliyon. 2020 Jun 24;6(6):e04315. doi: 10.1016/j.heliyon.2020.e04315. eCollection 2020 Jun.
7
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
8
Novel insights on the pulmonary vascular consequences of COVID-19.
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L277-L288. doi: 10.1152/ajplung.00195.2020. Epub 2020 Jun 17.
9
New-Onset Diabetes in Covid-19.
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
10
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa342.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验